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Fat necrosis of the breast is a challenging diagnosis due to the various appearances on mammography, ultrasound, CT, PET-CT,
and MRI. Although mammography is more specific, ultrasound is a very important tool in making the diagnosis of fat necrosis.
MRI has a wide spectrum of findings for fat necrosis and the appearance is the result of the amount of the inflammatory reaction,
the amount of liquefied fat, and the degree of fibrosis. While CT and PET-CT are not first line imaging examinations for the
diagnosis of breast cancer or fat necrosis, they are frequently performed in the surveillance and staging of disease. Knowledge of
how fat necrosis presents on these additional imaging techniques is important to prevent misinterpretation of the imaging findings.
Gross and microscopic appearances of fat necrosis depend on the age of the lesion; the histologic examination of fat necrosis is
usually straightforward. Knowledge of the variable appearances of fat necrosis on a vast array of imaging modalities will enhance a
radiologist’s accuracy in the analysis and interpretation of fat necrosis versus other diagnoses.
1. Introduction
Fat necrosis is a benign nonsuppurative inflammatory pro-
cess of adipose tissue. It is important to diagnose fat necrosis
because it can often mimic carcinoma of the breast. Fat
necrosis in the breast is a common pathologic condition
with a wide variety of presentations on mammography,
ultrasound, and MRI.
The incidence of fat necrosis of the breast is estimated to
be 0.6% in the breast, representing 2.75% of all breast lesions.
Fat necrosis is found to be 0.8% of breast tumors and 1%
in breast reduction mammoplasty cases. The average age of
patients is 50 years [1].
Fat necrosis is most commonly the result of trauma to the
breast (21–70%), radiotherapy, anticoagulation (warfarin),
cyst aspiration, biopsy, lumpectomy, reduction mammo-
plasty, implant removal, breast reconstruction with tissue
transfer, duct ectasia, and breast infection. Other rare
causes for fat necrosis include polyarteritis nodosa, Weber-
Christian disease, and granulomatous angiopanniculitis. In
some patients, the cause for fat necrosis is unknown [1].
The typical clinical presentation of fat necrosis can range
from an incidental benign finding to a lump. However, in
around half of the cases patients do not report any injury
to the breast and are clinically occult. Following injury to
breast tissue, hemorrhage in the fat leads to induration and
firmness, which demarcates andmay result in a cavity caused
by cystic degeneration. The clinical features of fat necrosis
vary from indolent single or multiple smooth round nodules
to clinically worrisome fixed, irregular masses with overlying
skin retraction [2–6]. Other clinical features associated with
fat necrosis include ecchymosis, erythema, inflammation,
pain, skin retraction or thickening, nipple retraction, and
occasionally lymphadenopathy [1, 2].There is little difference
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Figure 1: 49-year-old female with history of left modified radical mastectomy with transverse rectus abdominis myocutaneous (TRAM) flap
reconstruction. Left TRAM flap reconstruction craniocaudal and mediolateral oblique projections ((a) and (b)) demonstrate a large mass
of dystrophic calcification and fat. MRI breast T1-weighted nonfat saturation (c), T1-weighted fat saturation after gadolinium (d), and T2-
weighted fat saturation images (e) demonstrate a mass in the central left TRAM which follows fat signal on all pulse sequences with a thin
rim of enhancement (arrow).The biopsy ((f); H&E, 400x) demonstrating dense fibrotic tissue with foamy histiocytes (left) and hemosiderin-
laden macrophages (upper and right). Rebiopsy ((g); H&E, 400x) demonstrating fibrous paucicellular cyst wall (left) surrounded by massive
accumulation of foamy histiocytes (center and right).
in the clinical presentations of fat necrosis regardless of
whether they are related to trauma. In cases related to trauma,
the majority of patients presented with a breast lump. The
mean time of patients to present with a breast lump from time
of trauma is 68.5 weeks. Fat necrosis is commonly seen in
the superficial breast tissues and subareolar regions in obese
women with pendulous breasts [1].The aim of this paper is to
review the histopathological and radiological features of fat
necrosis of the breast which distinguishes it from a cancer.
2. Histopathologic Findings of Fat Necrosis
Gross and microscopic appearances of the fat necrosis
depend on the age of the lesion.Macroscopically, early lesions




Figure 2: 51-year-old female with history of right lobular carcinoma in situ status after lumpectomy and radiation now with palpable lump.
Right breast mediolateral oblique and craniocaudal projections ((a) and (b)) demonstrate a radiolucent lobular mass at site of palpable mass
(arrow). Targeted ultrasound (c) at site of palpable mass shows a lobular heterogeneous hypoechoic mass with posterior acoustic shadowing.
Axial T1-weighted fat saturation after gadolinium, T2-weighted nonfat saturation, and subtraction images ((d)–(f)) demonstrate a mass at 11
o’clock in the right breast anteriorly that follows fat signal on all sequences with thin rim enhancement (arrow). Histologically, tissue specimen
((g); H&E, 400x) demonstrating dead, anucleated adipocytes intermixed with foamy histiocytes.
appear as hemorrhagic foci or areas of indurated fat. In time,
the lesion may become bright yellow (saponification), chalky
white (calcification), or yellow-gray (fibrosis). Some lesions
may develop a central cavity because of liquefactive necrosis
(Figure 1). Poppiti Jr. et al. referred to such cystic lesions as
membranous fat necrosis [7]. Microscopically, early lesions
show hemorrhage, anucleated adipocytes, foamy (lipid-
laden) histiocytes, and multinucleated giant cells (Figure 2).
Older lesions develop fibrosis with a few foamy histiocytes
and multinucleated giant cells (Figures 3 and 4). However,
the latter are usually seen even in older foci of fat necrosis
which underwent subsequent transformation. Hemosiderin-
laden macrophages may be seen as a morphologic evidence
of remote hemorrhage (Figure 1). Dystrophic calcification
may occur in older lesions. The morphologic examina-
tion of fat necrosis is usually straightforward. If needed,
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Figure 3: 78-year-old female with palpable right breast masses. Right breast mediolateral oblique and craniocaudal mammograms ((a) and
(b)) demonstrate round masses with radiolucent centers at the site of palpable finding (arrow). Ultrasound of the right breast (c) at site
of palpable finding demonstrate two hypoechoic round masses with central echogenicity with associated posterior acoustic shadowing.
Hematoxylin and eosin (H&E, 200x) slide (d) shows fibrous areas around excision cavity with mixed chronic inflammatory cells, foamy
histiocytes, and occasional giant cells.
the histogenesis of foamy histiocytes may be confirmed by
positive CD68 and negative pan cytokeratin immunostains.
However, older lesions with prominent fibrosis may warrant
a more scrutinized examination of the specimen and pan
cytokeratin immunostaining to rule out invasive lobular
carcinoma in which discohesive single cells with small
monomorphic nuclei infiltrate the stroma [8].
3. Imaging Findings of Fat Necrosis
On mammography, common findings of fat necrosis are
oil cysts (Figure 5), coarse calcifications, focal asymmetries,
microcalcifications, or spiculated masses. Lipid cysts are
pathognomonic of benign fat necrosis, although the fibrous
rim of the cyst may calcify or collapse and may produce
an appearance that is mammographically indeterminate and
requires biopsy to exclude malignancy (Figure 3). Calcifica-
tions may form in the cyst walls and are frequently seen on
mammography, usually as smooth and round or curvilinear.
Calcificationsmay be the only findings butmay be of concern
if they are branching, rod-like, or angular [9]. The clustered,
pleomorphic microcalcifications may be indistinguishable
from those of malignancy (Figure 4) [10, 11]. When fibrosis
is present but the radiolucent fat is not completely replaced,
the oil cyst may have thickened, irregular, spiculated, or
ill-defined walls. Fibrosis may lead to replacement of the
radiolucent necrotic fat, resulting in the appearance of a focal
asymmetric density, a focal dense mass, or an irregular spic-
ulated mass on mammography [12]. Oil cysts with fat-fluid
levels or serous-hemorrhagic contents, collapsed cysts, and
cysts containing spherical densities are all atypical features of
fat necrosis.
On sonography, the appearance of fat necrosis ranges
from a solid hypoechoic mass with posterior acoustic shad-
owing to complex intracystic masses that evolve over time.
These features depict the histological evolution of fat necrosis.
Fat necrosis may appear as cystic or solid masses. Cystic
lesions appear complex with mural nodules or internal
echogenic bands. Solid masses have circumscribed or ill-
defined margins and are often associated with distortion
of the breast parenchyma [13]. In a retrospective study
of the clinical, mammographic, and sonographic features
of fat necrosis by Bilgen et al., 26.9% of lesions demon-
strated increased echogenicity of the subcutaneous tissue
with or without small cysts, 16.6% were anechoic masses
with posterior acoustic enhancement, 14.2% were solid-
appearing masses, 11.1% had cystic masses with internal
echoes, and 3.9% had cystic masses with mural nodules [14].
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Figure 4: 85-year-old female with history of right breast mucinous carcinoma, lobular carcinoma in situ (LCIS), and ductal carcinoma
in situ (DCIS) status after lumpectomy and radiation. Right breast mammogram ((a) and (b)) craniocaudal and mediolateral oblique
views demonstrate a radiolucent round mass with dystrophic calcifications (arrow) (c). Targeted ultrasound demonstrates a heterogeneous
hypoechoic mass with areas of posterior acoustic shadowing. The biopsy ((d); H&E, 400x) demonstrating dense fibrotic tissue with mixed
chronic inflammatory infiltrate and scattered foamy histiocytes.
(a) (b)
Figure 5: 69-year-old asymptomatic female with a stable screening mammogram for 18 years. Left breast mammogram craniocaudal and
mediolateral oblique projections demonstrate two round masses with radiolucent centers at 12 o’clock position anteriorly.
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Figure 6: Axial T1-weighted nonfat saturation, T2-weighted nonfat saturation, and T1-weighted fat saturation after gadolinium and
subtraction images ((a)–(d)) demonstrate a mass in the left breast which follows fat signal on all sequences (arrow). Histologically, excision
((e); H&E, 400x) shows collection of multinucleated cells in a fibrous area around excision cavity.
A specific sonographic indicator of fat necrosis is a mass
with echogenic internal bands that shift in orientation with
changes in patient position [15]. Hyperechoic masses very
rarely represent malignancy; in fact, hyperechoic cancers are
reported in less than 0.8% of tumors [16]. Although rare,
malignant hyperechoic lesions include invasive ductal and
lobular carcinoma, lymphoma, angiosarcoma, and liposar-
coma [16].The associated ultrasound characteristics (margin,
shape, and hypervascularity) are important to consider when
determining follow-up or when determining whether core
needle biopsy is needed [16].
MRI also has a wide spectrum of findings for fat necrosis
and the appearance is the result of the amount of the inflam-
matory reaction, the amount of liquefied fat, and the degree
of fibrosis. The most common appearance of fat necrosis on
MRI is a lipid cyst, round or oval mass with hypointense T1-
weighted signal on fat saturation images [17]. Fat necrosis is
usually isointense to fat elsewhere in the breast (Figure 2) and
shows low signal intensity on T1-weighted MRI, which may
be due to its hemorrhagic and inflammatory content [17].
Fat necrosis may show focal or diffuse and homogeneous or
heterogeneous enhancement after the administration of IV
paramagnetic contrast material.The amount of enhancement
is correlated with the intensity of the inflammatory process
[17]. As the high signal of fat interferes with the detection of
enhancing lesions on MRI, fat suppression is important for
identifying enhancing breast cancers or enhancing regions of
fat necrosis on MRI [15]. As mentioned before, fat necrosis is
usually isointense to fat elsewhere in the breast, a key to diag-
nosis (Figure 6). In cases where fat necrosis is not isointense,
the T1-weighted signal may be lower than fat elsewhere in the
breast [12]. Another useful technique for ruling out necrotic
tumors is using unenhanced non-fat-saturated T1-weighted
images to evaluate the degree of lipid cyst formation, looking
for a thin rim of enhancement [17]. Further, the “black hole”
sign has been described as another characteristic on MRI
to help diagnose fat necrosis, marked central hypointensity
of the lesion on short tau inversion recovery (STIR) images
when compared with surrounding fat [18]. Fat necrosis may
mimic malignancy with varying appearances on MRI. Thin
rim of enhancement (Figure 1) is common although it may
also be thick, irregular, or spiculated, which are features of
recurrent or residual cancer. Another confounding factor in
the diagnosis is the different appearance that fat necrosis may
have in the same patient. Kinetic analysis may be of little help
because fat necrosis exhibits the full spectrum of benign and
malignant enhancement patterns. Fat necrosis may also show
FDG uptake on PET [19].
CT is not typically included in the imaging protocol
for breast cancer detection; however, cancer patients may
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Table 1: Common imaging features of fat necrosis.
Mammography
(i) Wide spectrum ranging from benign to indeterminate to malignant appearing masses or calcification
(ii) Visualized masses may be as follows:
(a) radiolucent with a thin, well-defined capsule
(b) both radiolucent and dense with encapsulation
(c) dense and circumscribed mass
(d) mass with indistinct margins
(e) mass with spiculated margins
Ultrasound
(i) Sonographic spectrum with two most common appearances:
(a) mass (anechoic, hypoechoic, isoechoic, or hyperechoic with or without shadowing and enhancement)
(b) area of increased echogenicity of the subcutaneous tissue with or without small cysts and architectural distortion
CT
(i) Liquefied fat demonstrates low attenuation coefficients
(ii) Fibrosis has attenuation similar to fibroglandular tissue or linear densities resembling fibrous bands
(iii) Inflammation enhances after contrast injection
PET-CT (i) Fat necrosis has increased FDG uptake secondary to presence of metabolically active inflammatory cells(ii) It may show intense activity in the setting of TRAM flap reconstruction
MRI
(i) Wide spectrum of appearance depending on amount of inflammatory reaction, liquefied fat, and degree of fibrosis
(ii) It may demonstrate enhancement following administration of IV paramagnetic contrast material depending on the
intensity of the inflammatory process
(iii) Most common appearance are lipid cyst, round or oval mass with hypointense T1-weighted signal on fat saturation
images
(iv) It is usually isointense to fat elsewhere in the breast
(v) “Black hole” sign, marked hypointensity on STIR images when compared with surrounding fat
(vi) It may mimic malignancy with thin, thick, irregular or spiculated enhancement
undergo chest CT as part of staging and surveillance. CT
can show areas of fat necrosis and knowledge of the CT
appearance will help prevent misinterpretation of the imag-
ing findings. The CT appearance is based on the main
components found in fat necrosis: liquefied fat, fibrosis, and
inflammation. Liquefied fat would present on CT as low
attenuation coefficients, fibrosis would present as soft tissue
coefficients similar to fibroglandular tissue or linear densities
resembling fibrous bands, and inflammation would present
with enhancement after contrast injection [12]. Calcifications
typically are not evident until later in the evolution of fat
necrosis when they become large in size.
Although F18-FDG PET/CT is not recommended for the
primary detection of breast cancer, it may play a role in
the detection of local recurrence or distant metastases in
the setting of locally advanced breast cancer when other
imaging modalities are equivocal or confounding [20].There
are several entities within the breast that will show increased
FDG-activity on PET/CT with F18-FDG.These include acute
and chronic inflammation, physiologic lactation, and benign
focal breast masses including fat necrosis amongst others.
Fat necrosis has increased FDG uptake secondary to the
presence of metabolically active inflammatory cells in early
stages of the process [19]. Fat necrosis of the breast is
often hypermetabolic on PET/CT and may show intense
FDG activity in the setting of transverse rectus abdominis
myocutaneous (TRAM) flap reconstruction if the fat-rich
tissue is damaged intraoperatively [21]. The presentation of a
patientwith a history of breast cancer status aftermastectomy,
palpable mass, and increased activity on PET/CT may be
concerning, although this entity is more likely to be fat
necrosis than recurrent tumor.
4. Conclusion
Fat necrosis of the breast may be a challenging diagnosis
as it has a wide variety of presentations on mammography,
ultrasound, CT, PET-CT, and MRI (Table 1). The extent of
associated fibrosis, liquefied fat, and calcifications determine
the imaging findings of fat necrosis. Mammography is more
specific, although ultrasound is still a very important tool
in making the diagnosis-increased echogenicity of subcuta-
neous tissue; in the event of recent trauma, it is the most
common presentation and hyperechoic masses are almost
always benign. MRI may be helpful in the diagnosis, for
example, when internal signal characteristics are identical to
those of the adjacent fat and no evidence of enhancement is
seen after IV contrast.
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